Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad?

被引：0
|
作者：
Alexopoulos, Dimitrios [1 ]
机构：
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 01期
关键词：
Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Reloading; CHRONIC CLOPIDOGREL THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ANTIPLATELET THERAPY; PLATELET INHIBITION; ANGIOPLASTY; TICAGRELOR; PRASUGREL;
D O I：
10.1016/j.ijcard.2012.09.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [1] Stent-PCI in ACS for Patients with VHF: P2Y12 Inhibitors are sufficient in addition to NOAC
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2022, 11 (05)
  • [2] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
    Ristorto, Jessica
    Messas, Nathan
    Marchandot, Benjamin
    Kibler, Marion
    Hess, Sebastien
    Meyer, Nicolas
    Schaeffer, Michael
    Tuzin, Nicolas
    Ohlmann, Patrick
    Jesel, Laurence
    Morel, Olivier
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
  • [3] Clinical effects and outcomes with new P2Y12 inhibitors in ACS
    Collet, Jean-Philippe
    O'Connor, Stephen
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (01) : 16 - 18
  • [4] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [5] Dropping P2Y12 inhibitors in patients with AF undergoing PCI? Not yet a SAFE bet
    Lopes, Renato D.
    Fanaroff, Alexander C.
    EUROINTERVENTION, 2020, 16 (02) : E109 - E111
  • [6] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [7] P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study
    Lee, Seung-Yul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B18 - B18
  • [8] P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients The MACT Pilot Study
    Lee, Seung-Yul
    Jeong, Young-Hoon
    Yun, Kyeong Ho
    Cho, Jae Young
    Gorog, Diana A.
    Angiolillo, Dominick J.
    Kim, Jin Won
    Jang, Yangsoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (15) : 1845 - 1855
  • [9] Initial choice and switching of P2Y12 inhibitors among patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI)
    Wang, Yehua
    Brown, Joshua
    Cavallari, Larisa
    Winterstein, Almut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 170 - 170
  • [10] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
12345